Drug News
-
PharmAbcine’s Study Highlights PMC-403’s Potential in Preclinical Models of Capillary Leak Syndrome
PharmAbcine, a clinical-stage biotech company, has published a study in Science Advances showcasing the potential of its Tie2-activating antibody program,…
Read More » -
Spasticity Market Likely to Exhibit Substantial Growth by 2032, Predicts DelveInsight
DelveInsight’s “Spasticity Market Insights” report offers a thorough understanding of the current treatment landscape, emerging drugs, market shares, and the…
Read More » -
RFID Technology Revolutionizes Global Healthcare Market, Offering Opportunities in Asset, Patient, and Pharmaceutical Tracking
The “RFID in Healthcare Market: Trends, Opportunities and Competitive Analysis (2023-2028)” report, recently added to ResearchAndMarkets.com’s offerings, presents a comprehensive…
Read More » -
Novo Nordisk to Invest $2.3 Billion in France for Production Expansion
Novo Nordisk A/S, the maker of Ozempic, is set to invest €2.1 billion ($2.3 billion) to expand production at its…
Read More » -
Global Pneumatic Nebulizers Market to Reach $962.6 Million by 2030
The global market for Pneumatic Nebulizers is projected to witness substantial growth, with an estimated value of US$962.6 Million by…
Read More » -
PCR Technology Market and Competitive Analysis Report 2023-2028
The global PCR (Polymerase Chain Reaction) technology market is anticipated to experience significant growth, reaching an estimated $13.9 billion by…
Read More » -
Artificial Intelligence (AI) in Genomics Market to Surpass US$ 19.72 Billion by 2030
The Global Artificial Intelligence (AI) in Genomics market is experiencing robust growth, with a market size of US$ 1.15 Billion…
Read More » -
Global Beta Blockers Market Set for Robust Growth with a CAGR of 5.19% and Market Value of $11.54 Billion by 2027
The global beta blockers market is positioned for substantial growth, with a projected compound annual growth rate (CAGR) of 5.19%…
Read More » -
InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program
Stockholm, Nov. 21, 2023 – InDex Pharmaceuticals Holding AB (publ) (“InDex Pharmaceuticals”) has announced the discontinuation of the phase III…
Read More » -
Gonorrhea Therapeutics Market to Grow by $506.68 Million From 2022 to 2027
The gonorrhea therapeutics market is anticipated to witness substantial growth, with a projected increase of USD 506.68 million from 2022…
Read More »